Financials

  • Market Capitalization 211.54 M
  • Employee 81
  • Founded 1999
  • CEO N/A
  • Website www.agenusbio.com
  • Headquarter Delaware, United States
  • FIGI BBG000C8SWQ9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
Rapporto prezzo/fatturato
0.82

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3577
CGEN
Compugen Ltd. - Ordinary Shares
2.30 USD0.00%-3.77%+13.86%+49.35%217.47 M USD
3589
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.21 USD-3.22%-3.00%+1.45%-45.47%212.07 M USD
3595
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
75.39 USD+2.00%-4.57%+3.26%+843.55%210.05 M USD
3599
KROS
Keros Therapeutics, Inc. - common stock
10.57 USD-4.77%-8.41%+3.12%-30.00%209.20 M USD

Notizie